(Q33952056)

30 July 2017

1 reference

title

Gamma-hydroxybutyric acid as a signaling molecule in brain (English)

1 reference

30 July 2017

Maitre M

1

1 reference

30 July 2017

Andriamampandry C

2

1 reference

30 July 2017

Kemmel V

3

1 reference

30 July 2017

Schmidt C

4

1 reference

30 July 2017

Hodé Y

5

1 reference

30 July 2017

Hechler V

6

1 reference

30 July 2017

Gobaille S

7

1 reference

30 July 2017

publication date

1 April 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

277-283

1 reference

Cloning of a rat brain succinic semialdehyde reductase involved in the synthesis of the neuromodulator gamma-hydroxybutyrate

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

High affinity binding sites for gamma-hydroxybutyric acid in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Purification from human brain and some properties of two NADPH-linked aldehyde reductases which reduce succinic semialdehyde to 4-hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Low doses of gamma-hydroxybutyric acid stimulate the firing rate of dopaminergic neurons in unanesthetized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Heterogeneous responses of substantia nigra pars reticulata neurons to gamma-hydroxybutyric acid administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Effect of gamma-hydroxybutyrate and its antagonist NCS-382 on spontaneous cell firing in the prefrontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Kinetics of in vivo conversion of gamma-[3H]aminobutyric acid to gamma-[3H]hydroxybutyric acid by rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

The effects of gamma-hydroxybutyrate on the membrane properties of guinea-pig pars compacta neurons in the substantia nigra in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Effects of phospholipases, proteases and neuraminidase on gamma-hydroxybutyrate binding sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Trans-gamma-hydroxycrotonic acid binding sites in brain: evidence for a subpopulation of gamma-hydroxybutyrate sites.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Selective distribution pattern of gamma-hydroxybutyrate receptors in the rat forebrain and midbrain as revealed by quantitative autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

gamma-Butyrolactone-induced absence-like seizures increase nuclear CRE- and AP-1 DNA-binding activities in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Neurochemical and electrophysiological evidence for the existence of a functional gamma-hydroxybutyrate system in NCB-20 neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Subcellular distribution of gamma-hydroxybutyrate binding sites in rat brain principal localization in the synaptosomal fraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Displacement of [3H] gamma-hydroxybutyrate binding by benzamide neuroleptics and prochlorperazine but not by other antipsychotics

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

The gamma-hydroxybutyrate signalling system in brain: organization and functional implications.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Treatment of narcolepsy with gamma-hydroxybutyrate. A review of clinical and sleep laboratory findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

The Extraneural Distribution of γ‐Hydroxybutyrate

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Inhibition of nigral and neocortical cells by γ-hydroxybutyrate: A microiontophoretic investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

gamma-Hydroxybutyrate receptor binding in rat brain is inhibited by guanyl nucleotides and pertussis toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Sulpiride, but not haloperidol, up-regulates gamma-hydroxybutyrate receptors in vivo and in cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Specific and non-specific succinic semialdehyde reductases from rat brain: isolation and properties

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Regional and Subcellular Localization in Rat Brain of the Enzymes That Can Synthesize γ‐Hydroxybutyric Acid

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Ontogeny and distribution of specific succinic semialdehyde reductase apoenzyme in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Anti-sedative and anti-cataleptic properties of NCS-382, a γ-hydroxybutyrate receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

The anxiolytic effect of gamma-hydroxybutyrate in the elevated plus maze is reversed by the benzodiazepine receptor antagonist, flumazenil.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

gamma-Hydroxybutyric acid in subcellular fractions of rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Evidence for GABAB-mediated mechanisms in experimental generalized absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

The ontogeny of [3H]gamma-hydroxybutyrate and [3H]GABAB binding sites: relation to the development of experimental absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

GABAA receptor function in the gamma-hydroxybutyrate model of generalized absence seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

γ-Hydroxybutyric acid binding sites: Interaction with the GABA-benzodiazepine-picrotoxin receptor complex

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Gamma-hydroxybutyrate stimulation of the formation of cyclic GMP and inositol phosphates in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

3'-5' cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

Gamma-hydroxybutyrate promotes oscillatory activity of rat and cat thalamocortical neurons by a tonic GABAB, receptor-mediated hyperpolarization.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

gamma-Hydroxybutyrate depresses monosynaptic excitatory and inhibitory postsynaptic potentials in rat hippocampal slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0741-8329%2899%2900092-0

7 January 2021

10.1016/S0741-8329(99)00092-0

Identifiers

DOI

1 reference

30 July 2017

1 reference